COLOCO prp | Neuroprotection
21949
page-template-default,page,page-id-21949,qode-social-login-1.0,qode-restaurant-1.0,ajax_fade,page_not_loaded,,select-theme-ver-4.5,popup-menu-slide-from-left,wpb-js-composer js-comp-ver-5.5.2,vc_responsive,elementor-default,elementor-page elementor-page-21949

Nervous system: neuroprotection

Neurodegenerative diseases are characterised by protein misfolding, aggregation and pathological accumulation. This neuropathology can be seen in many disorders, including:

  • Alzheimer’s disease (AD)
  • Parkinson’s disease (PD)
  • Amyotrophic lateral sclerosis (ALS)
  • Huntington’s disease (HD)

In case of Alzheimer’s disease (AD), neurotoxic Amyloid beta (Aβ) plaques can be found in the brain.

Our in vitro study proved that COLOCO prp inhibits and decreases Amyloid beta (Aβ) aggregation. Therefore, COLOCO prp could be used to prevent and support the treatment of neurodegenerative disorders such as Alzheimer’s disease.